Search

Your search keyword '"Tomazic PV"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Tomazic PV" Remove constraint Author: "Tomazic PV"
157 results on '"Tomazic PV"'

Search Results

1. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers

2. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

3. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

4. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

11. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

13. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

14. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study

15. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

16. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

17. Beurteilung von Nasennebenhöhlen-CT Scans bei Transplantatempfängern

22. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

23. Video endoscopic oro-nasal visualisation of the anterior wall of maxillary sinus: a new technique

24. Endoscopic transnasal intraorbital surgery: our experience with 16 cases

25. Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR).

26. Impact of Overweight on Response to Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps.

27. The value of beta trace protein in CSF-leakage detection confirmed by endoscopic fluorescein evaluation.

29. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.

30. Endoscopic trans-sphenoidal pituitary surgery does not impact postoperative nasal quality of life.

31. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study.

32. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

33. European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis.

34. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology.

35. The EUFOREA pocket guide for chronic rhinosinusitis.

36. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air ® approach.

37. Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.

38. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air ® real-world data.

39. Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.

40. Development and validation of combined symptom-medication scores for allergic rhinitis.

41. Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP).

42. Septoplasties are unlikely to cause postoperative numbness of the anterior palate.

43. Optic nerve injury in preoperative imaging is associated with visual improvement outcome in endoscopic optic nerve decompression.

44. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model.

45. T2-Inflammation bei entzündlichen Atemwegserkrankungen: Grundlage neuer Behandlungsoptionen.

46. Preservation of nasal turbinates in endoscopic, anterior skull base surgery-yes, we can!

47. Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing loss.

49. Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity : A single center experience and review of literature.

50. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.

Catalog

Books, media, physical & digital resources